Big Moving Stocks for Sep-4 At The Close

These stocks are posting some big moves for today.

Kalobios Pharmaceuticals Inc (KBIO) < (KBIO) is currently trading at $3.90 + 0.87 (28.71%) on 17,565,218 shares traded. Kalobios Pharmaceuticals Inc (KBIO) < is -71.82% year-to-date, and -67.87% over the last 12 months.

KaloBios Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in the development of monoclonal antibody therapeutics for diseases that burdens the society and to patients and their families.

Heat Biologics Inc (HTBX) < (HTBX) is currently trading at $3.84 + 0.4201 (12.28%) on 117,246 shares traded. Heat Biologics Inc (HTBX) < is -16.34% year-to-date, and -42.23% over the last 12 months.

Heat Biologics Inc is a development stage biopharmaceutical company. The Company is engaged in the development of novel allogeneic, ‘off-the-shelf’ cellular therapeutic vaccines to combat various cancers and infectious diseases.

Trevena Inc (TRVN) < (TRVN) is currently trading at $10.96 + 1.07 (10.79%) on 3,426,352 shares traded. Trevena Inc (TRVN) < is +83.23% year-to-date, and +88.44% over the last 12 months.

Trevena Inc is a clinical stage biopharmaceutical company. The Company discovers, develops and commercialize therapeutics that use a novel approach to target G protein coupled receptors, or GPCRs.

Streamline Health Solutions Inc. (STRM) < (STRM) is currently trading at $2.83 + 0.2476 (9.60%) on 226,926 shares traded. Streamline Health Solutions Inc. (STRM) < is -34.70% year-to-date, and -40.75% over the last 12 months.

Streamline Health Solutions Inc is a provider of transformational data-driven solutions for healthcare organizations. The Company provides computer software-based solutions through its Looking Glass platform.

Akebia Therapeutics Inc  (AKBA) < (AKBA) is currently trading at $7.15 + 0.569 (8.65%) on 187,693 shares traded. Akebia Therapeutics Inc  (AKBA) < is -38.58% year-to-date, and -68.39% over the last 12 months.

Akebia Therapeutics Inc is a biopharmaceutical company. It is engaged in the development of proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease.

Carbylan Therapeutics Inc (CBYL) < (CBYL) is currently trading at $5.40 + 0.41 (8.22%) on 55,059 shares traded. Carbylan Therapeutics Inc (CBYL) < is -- year-to-date, and -- over the last 12 months.

Carbylan Therapeutics Inc is a clinical-stage specialty pharmaceutical company. The Company is engaged in the development and commercialization of novel and proprietary combination therapies that address significant unmet medical needs.

Sears Hometown and Outlet Stores Inc. (SHOS) < (SHOS) is currently trading at $7.57 + 0.57 (8.14%) on 204,385 shares traded. Sears Hometown and Outlet Stores Inc. (SHOS) < is -42.43% year-to-date, and -59.87% over the last 12 months.

Sears Hometown & Outlet Stores Inc is a national retailer engaged in selling home appliances, lawn and garden equipment, tools, and hardware.

Republic Airways Holdings Inc. (RJET) < (RJET) is currently trading at $3.24 + 0.215 (7.12%) on 3,362,901 shares traded. Republic Airways Holdings Inc. (RJET) < is -77.83% year-to-date, and -67.69% over the last 12 months.

Republic Airways Holdings Inc offers scheduled passenger services through its wholly-owned operating air carrier subsidiaries: Chautauqua Airlines, Inc., Shuttle America Corporation and Republic Airline Inc.

IGNYTA INC (RXDX) < (RXDX) is currently trading at $15.26 + 0.99 (6.94%) on 198,103 shares traded. IGNYTA INC (RXDX) < is +122.77% year-to-date, and +105.42% over the last 12 months.

Ignyta Inc is a precisionu00A0oncologyu00A0biotechnology company. It is dedicated to discovering or acquiring, thenu00A0developing and commercializing, precisely targeted new drugs for cancer patients whose tumors harbor specific molecular alterations.

Presbia PLC (LENS) < (LENS) is currently trading at $7.00 + 0.43 (6.54%) on 5,400 shares traded. Presbia PLC (LENS) < is -- year-to-date, and -- over the last 12 months.

Presbia PLC manufactures ophthalmic device. The Company is engaged in developing and marketing a proprietary optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects.

Alex Fredricks

Alex Fredricks

Alex Fredricks has a degree in business and is an avid day-trader. Alex's experience and love for the game of the markets is shown not only in his posts, but the post he helps edit for other authors on our staff.